Avalo Therapeutics, Inc. (AVTX)
19.26
-0.57
(-2.87%)
USD |
NASDAQ |
Aug 24, 16:00
19.26
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Total Assets (Quarterly) : 490.78M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 490.78M |
| March 31, 2026 | 99.88M |
| December 31, 2025 | 117.70M |
| September 30, 2025 | 125.10M |
| June 30, 2025 | 126.58M |
| March 31, 2025 | 138.52M |
| December 31, 2024 | 150.73M |
| September 30, 2024 | 98.46M |
| June 30, 2024 | 108.31M |
| March 31, 2024 | 123.73M |
| December 31, 2023 | 20.99M |
| September 30, 2023 | 29.27M |
| June 30, 2023 | 24.24M |
| March 31, 2023 | 36.24M |
| December 31, 2022 | 33.37M |
| September 30, 2022 | 36.55M |
| June 30, 2022 | 32.22M |
| March 31, 2022 | 61.90M |
| December 31, 2021 | 80.21M |
| September 30, 2021 | 95.36M |
| June 30, 2021 | 64.08M |
| March 31, 2021 | 63.34M |
| December 31, 2020 | 43.76M |
| Date | Value |
|---|---|
| September 30, 2020 | 59.19M |
| June 30, 2020 | 69.20M |
| March 31, 2020 | 44.12M |
| December 31, 2019 | |
| September 30, 2019 | 57.19M |
| June 30, 2019 | 59.62M |
| March 31, 2019 | 74.87M |
| December 31, 2018 | 70.34M |
| September 30, 2018 | 67.61M |
| June 30, 2018 | 62.15M |
| March 31, 2018 | 65.36M |
| December 31, 2017 | 43.12M |
| September 30, 2017 | 28.20M |
| June 30, 2017 | 6.048M |
| March 31, 2017 | 3.561M |
| December 31, 2016 | 5.769M |
| September 30, 2016 | 9.583M |
| June 30, 2016 | 13.17M |
| March 31, 2016 | 16.93M |
| December 31, 2015 | 21.66M |
| September 30, 2015 | 5.451M |
| June 30, 2015 | 7.582M |
| March 31, 2015 | 9.170M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Incyte Corp. | 7.873B |
| AbbVie, Inc. | 135.12B |
| Rezolute, Inc. | 125.46M |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 42.12M |
| Shareholders Equity (Quarterly) | 448.66M |
| Debt to Equity Ratio | 0.005 |
| Current Ratio | 19.31 |
| Net Debt Paydown Yield | 0.01% |